Ranbaxy Laboratories Limited News and Updates

Keep track of all breaking news on Ranbaxy Laboratories Limited from all sources in a single place.

Load latest

Ranbaxy Laboratories Limited

31 Jan 2018

Dai-ichi Kakaria rises in a case of mistaken identity with Daiichi Sankyo

Business Line

Stock spikes 11% after judgment favouring Daiichi Sankyo in dispute with Ranbaxy

Ranbaxy Laboratories Limited

30 Jan 2018

Top Indian lawyers to argue Ranbaxy-Daiichi appeal in Singapore

livemint

Ranbaxy has roped in senior advocate Harish Salve to argue the case in the Singapore high court, while Daiichi has assigned advocate Gopal Subramanium for its team

Ranbaxy Laboratories Limited

22 Nov 2017

India's top lawyers, Gopal Subramanium and Harish Salve set to clash in Singapore court

Economic Times

Subramanium will take on Salve in an arbitration award challenge by former Ranbaxy promoters Malvinder and Shivinder Singh against Japan's Daiichi Sankyo in Singapore.

Ranbaxy Laboratories Limited

16 Jun 2017

Ranbaxy recalls deworming medicine in South Africa

Business Line

No information on how Ranbaxy had discovered the fault in the product or how many bottles were in circulation.

Ranbaxy Laboratories Limited

27 Apr 2017

Singh brothers question Daiichi allegations of misrepresentation in HC

Business Standard

Senior advocate Harish Salve, appearing on behalf of Malvinder and Shivinder Singh told the Delhi High Court on Wednesday that Daiichi Sankyo had full knowledge of all affairs of Ranbaxy Laboratories while purchasing stake in the company in 2008. Highlighting an extensive series of e-mails between several members of Daiichi's top brass during the time of the negotiations, Salve told the court that the Japanese pharmaceutical major's claims of misrepresentation of critical information about the internal issues of Ranbaxy was merely a farce to now extract unjustified reparations from the Singh brothers. "Even after having the knowledge of the situation, Daiichi bought the company nonetheless. Now they (Daiichi) make tall claims of misrepresentation. These (Daiichi's senior management) are hardened negotiators, not simpletons being mislead in any manner," said Salve in court.In support of this stance, the lawyer for the former Ranbaxy promoters also showed the court that Daiichi chose ..

Ranbaxy Laboratories Limited

29 Mar 2017

Ranbaxy's Singh brothers known for lucky timing find time in short supply

Business Standard

Singh brothers face legal woes from 2008 sale of Ranbaxy

Shivinder and Malvinder Singh want to sell some assets, but the timing isn't right

livemint | 28 Mar 2017

Ranbaxy Laboratories Limited

18 Jan 2017

Daiichi Sankyo stumps industry with move to pull the plug on Indian Research and development arm

Business Today

Its misadventure in India had began in June 2008 with the acquisition of Ranbaxy in an over $4-billion deal (around Rs 20,000 crore then) with the promise of utilising Ranbaxy's resources to become a 'global pharma innovator'.

Ranbaxy Laboratories Limited

25 Dec 2016

Ranbaxy portfolio makes up for 37% of Sun's India sales

Business Standard

Currently, Ranbaxy contributes a little lower than Rs 3,000 crore to the India sales of the merged entity

Ranbaxy Laboratories Limited

20 Dec 2016

Withdraw nod for 28 drug applications of Ranbaxy: Sun Pharma to USFDA

livemint

These older drug products belong to erstwhile Ranbaxy Laboratories and are not being marketed in the US since 2008

Ranbaxy seeks USFDA nod for withdrawing 28 drug applications

Business Standard | 20 Dec 2016

Ranbaxy Laboratories Limited

23 Aug 2016

Daiichi case: Former Ranbaxy promoters object to enforcement of Singapore arbitration award in India

Business Standard

Malvinder Singh and Shivinder Singh were accused of concealing information regarding wrongdoing at Ranbaxy when they sold a majority stake in it to the Japanese firm in 2008

Is Ranbaxy Laboratories Limited worth buying?

5 Votes:

Buy 40.0%

Hold 60.0%